Trials / Completed
CompletedNCT00622908
Clinical and Microbial Efficacy of ISV403 in Bacterial Conjunctivitis
A Study to Evaluate the Clinical and Microbial Efficacy of 0.6% ISV-403 Compared to Vehicle in the Treatment of Bacterial Conjunctivitis
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 270 (actual)
- Sponsor
- Bausch & Lomb Incorporated · Industry
- Sex
- All
- Age
- 1 Year
- Healthy volunteers
- Not accepted
Summary
To evaluate the clinical and microbial efficacy of ISV-403 administered three times a day (TID) for 5 days compared to vehicle three times a day for 5 days in the treatment of bacterial conjunctivitis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ISV-403 | 0.6% TID, 5 days |
| DRUG | Vehicle | Vehicle of ISV-403 TID, 5 days |
Timeline
- Start date
- 2004-12-01
- Primary completion
- 2005-06-01
- Completion
- 2005-06-01
- First posted
- 2008-02-25
- Last updated
- 2015-03-24
- Results posted
- 2009-08-13
Source: ClinicalTrials.gov record NCT00622908. Inclusion in this directory is not an endorsement.